These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23987918)
1. Prevalence of schistosome antibodies with hepatosplenic signs and symptoms among patients from Kaoma, Western Province, Zambia. Payne L; Turner-Moss E; Mutengo M; Asombang AW; Kelly P BMC Res Notes; 2013 Aug; 6():344. PubMed ID: 23987918 [TBL] [Abstract][Full Text] [Related]
2. Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo. Nigo MM; Odermatt P; Nigo DW; Salieb-Beugelaar GB; Battegay M; Hunziker PR PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009375. PubMed ID: 34855763 [TBL] [Abstract][Full Text] [Related]
3. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors. Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657 [TBL] [Abstract][Full Text] [Related]
5. Hepatosplenic morbidity due to Schistosoma mansoni in schoolchildren on Ukerewe Island, Tanzania. El Scheich T; Hofer L; Kaatano G; Foya J; Odhiambo D; Igogote J; Lwambo N; Ekamp H; Karst K; Häussinger D; Richter J Parasitol Res; 2012 Jun; 110(6):2515-20. PubMed ID: 22215193 [TBL] [Abstract][Full Text] [Related]
6. Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis. Sinkala E; Kapulu MC; Besa E; Zyambo K; Chisoso NJ; Foster GR; Kelly P Liver Int; 2016 Jan; 36(1):145-50. PubMed ID: 26058680 [TBL] [Abstract][Full Text] [Related]
7. High Schistosoma mansoni disease burden in a rural district of western Zambia. Mutengo MM; Mwansa JC; Mduluza T; Sianongo S; Chipeta J Am J Trop Med Hyg; 2014 Nov; 91(5):965-72. PubMed ID: 25246696 [TBL] [Abstract][Full Text] [Related]
8. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364 [TBL] [Abstract][Full Text] [Related]
9. Clinical and endoscopic aspects of hepatosplenic schistosomiasis in Uganda. Ravera M; Reggiori A; Cocozza E; Ciantia F; Riccioni G Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):693-7. PubMed ID: 8853260 [TBL] [Abstract][Full Text] [Related]
10. Patients with severe schistosomiasis mansoni in Ituri Province, Democratic Republic of the Congo. Nigo MM; Odermatt P; Nigo DW; Salieb-Beugelaar GB; Battegay M; Hunziker PR Infect Dis Poverty; 2021 Mar; 10(1):39. PubMed ID: 33762007 [TBL] [Abstract][Full Text] [Related]
11. Contribution of Schistosoma mansoni to systemic inflammation and microbial translocation among people with HIV in Zambia. Furch BD; Mwakamui S; Sianongo S; Zyambo K; Heimburger DC; Koethe JR; Kelly P Trans R Soc Trop Med Hyg; 2022 Feb; 116(2):179-186. PubMed ID: 34263318 [TBL] [Abstract][Full Text] [Related]
12. Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis. Vennervald BJ; Kenty L; Butterworth AE; Kariuki CH; Kadzo H; Ireri E; Amaganga C; Kimani G; Mwatha J; Otedo A; Booth M; Ouma JH; Dunne DW Trop Med Int Health; 2004 Apr; 9(4):461-70. PubMed ID: 15078264 [TBL] [Abstract][Full Text] [Related]
13. High levels of IgG4 to Schistosoma mansoni egg antigens in individuals with periportal fibrosis. Silveira AM; Bethony J; Gazzinelli A; Kloos H; Fraga LA; Alvares MC; Prata A; Guerra HL; Loverde PT; Correa-Oliveira R; Gazzinelli G Am J Trop Med Hyg; 2002 May; 66(5):542-9. PubMed ID: 12201588 [TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters. Kardorff R; Gabone RM; Mugashe C; Obiga D; Ramarokoto CE; Mahlert C; Spannbrucker N; Lang A; Günzler V; Gryseels B; Ehrich JH; Doehring E Trop Med Int Health; 1997 Mar; 2(3):230-9. PubMed ID: 9491101 [TBL] [Abstract][Full Text] [Related]
15. Comparison of immune responses of Schistosoma mansoni-infected mice with distinct chronic forms of the disease. Silva LM; Oliveira SA; Ribeiro-dos-Santos R; Andrade ZA; Soares MB Acta Trop; 2004 Jul; 91(2):189-96. PubMed ID: 15234668 [TBL] [Abstract][Full Text] [Related]
16. [Decompensated post-schistosomiasis portal hypertension in Richard-Toll, Senegal: first case treated by splenorenal anastomosis in Dakar]. Imbert P; Gérardin P; Ka AS; Andreu JM; Cassagnou M; Klotz F Bull Soc Pathol Exot; 2003 Aug; 96(3):196-9. PubMed ID: 14582295 [TBL] [Abstract][Full Text] [Related]
17. Urban schistosomiasis: morbidity, sociodemographic characteristics and water contact patterns predictive of infection. Firmo JO; Lima Costa MF; Guerra HL; Rocha RS Int J Epidemiol; 1996 Dec; 25(6):1292-300. PubMed ID: 9027538 [TBL] [Abstract][Full Text] [Related]
18. The epidemiology of schistosomiasis in Egypt: Gharbia Governorate. El-Hawey AM; Amr MM; Abdel-Rahman AH; El-Ibiary SA; Agina AM; Abdel-Hafez MA; Waheeb AA; Hussein MH; Strickland GT Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):42-8. PubMed ID: 10813499 [TBL] [Abstract][Full Text] [Related]
19. Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel. Sukwa TY; Bulsara MK; Wurapa FK J Trop Med Hyg; 1987 Aug; 90(4):205-11. PubMed ID: 3116277 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]